ITGR vs. MASI, LIVN, TMDX, CNMD, SLNO, INMD, CRNX, PACS, SMMT, and INSM
Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Masimo (MASI), LivaNova (LIVN), TransMedics Group (TMDX), CONMED (CNMD), Soleno Therapeutics (SLNO), InMode (INMD), Crinetics Pharmaceuticals (CRNX), PACS Group (PACS), Summit Therapeutics (SMMT), and Insmed (INSM). These companies are all part of the "medical" sector.
Masimo (NASDAQ:MASI) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.
Masimo presently has a consensus price target of $138.71, indicating a potential upside of 20.54%. Integer has a consensus price target of $128.67, indicating a potential upside of 10.24%. Given Integer's higher possible upside, research analysts clearly believe Masimo is more favorable than Integer.
Masimo received 76 more outperform votes than Integer when rated by MarketBeat users. Likewise, 63.84% of users gave Masimo an outperform vote while only 63.51% of users gave Integer an outperform vote.
Integer has lower revenue, but higher earnings than Masimo. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.
In the previous week, Masimo and Masimo both had 26 articles in the media. Masimo's average media sentiment score of 0.48 beat Integer's score of 0.37 indicating that Integer is being referred to more favorably in the news media.
86.0% of Masimo shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 9.7% of Masimo shares are owned by insiders. Comparatively, 2.0% of Integer shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Integer has a net margin of 6.01% compared to Integer's net margin of 4.01%. Integer's return on equity of 13.26% beat Masimo's return on equity.
Masimo has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.
Summary
Masimo beats Integer on 9 of the 17 factors compared between the two stocks.
Get Integer News Delivered to You Automatically
Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools